Citigroup: Buy Now And Hold For 2 Years July 19,

New Post Public Reply Private Reply Replies (0) Message Board
Bible Feed

Citigroup: Buy Now And Hold For 2 Years

July 19, 2012

Citigroup Inc. ( C ) is America's third largest bank by assets with about $1.95 trillion on its balance sheet, and among the Financial Stability Board's 29 Global Banks that are Too Big to Fail . It released its second-quarter earnings, eking out a solid bottom line figure of $2.9 billion, or $0.95 per share.

Excluding one-time factors—primarily the bank's credit and debit evaluation adjustments of a positive $219 million and its loss of $424 million from the sale of about half its interest in Turkish bank Akbank Turk Ano Adr ( AKBTY.PK )—its earnings would have been $3.1 billion, or $1 per share. In last year's second quarter, Citigroup earned after adjusting for myriad one-time events, $1.01 per share. Analysts were expecting, on average, $0.89 per share. Therefore, on the basis of expectations, the quarter was a success. Let's take a closer look.

While Citigroup reports consolidated financial reports, several years ago, it divided itself into two companies—"good Citi" is anything associated with the title "Citibank", and "Bad City" is known as Citi Holdings, holding the loans and other assets that Citigroup wished in 2008 it did not have. That included all commercial and residential mortgage loans, student loans, and auto loans. It is not that Citigroup has stopped writing mortgages, or auto loans. Since 2009 though, it has been able in its financial reports to segregate the good Citi from bad Citi, which is both misleading and confusing.

Citigroup is not the only financial group that brought onto itself billions of worthless mortgages in the late 2000s. But Wells Fargo & Co. 's ( WFC ) purchase of Wachovia was far larger than Citigroup's biggest domestic purchase ever—that of Golden West thrift 's parent in 2002—and Wells Fargo does not run a separate balance sheet, though it does occasionally refer to "legacy assets." Any of Citigroup's asset issues are its own doing, and it is horrible hypocrisy to imply that mortgage assets are "non-core," while at the same time operating a large, core mortgage operation.

I bring this up because the core part of Citigroup is actually performing quite well. Citi Holdings is in liquidation mode, and quarter after quarter is a drag on overall assets, revenues and earnings. Of course, none of that is a surprise. It is the implication that Citi Holdings is separate that has been done now for several years. Citi Holdings, which at one time held some 40% of Citigroup's assets, is now down to under 10% of overall assets with about $190 billion.

Revenues in the second quarter came to $18.6 billion or $18.8 billion if we exclude the one-time factors. The most salient feature of Citigroup's income statement is the enormous release of reserves it still is posting. Over the past four quarters, Citigroup's overall reserve for credit losses has fallen from $34.4 billion to $27.6 billion. Specifically, in the just concluded second quarter, there was a reserve release of $984 million, accounting for about one-third of the quarter's profit amount.

A reserve release is distinct from provisions for loss, and in that regard, Citigroup's provision for loan losses of $214 million was little changed from the year ago's $219 million. Citigroup obviously believes it was overaggressive in reserving over the last several years, and now can afford to let credit losses be absorbed as its customers' credit environment improves.

Management has announced its intent to have its large, global consumer bank become more focused on emerging economies around the globe. I will note that among North America, Europe / Middle East / Africa, Latin America, and Asia, the only geographic unit to report a year-over-year revenue or income increases was the North American unit.

Time will tell weather Citigroup's worldwide campaign works for it. I might also add that the two most profitable large banks in this country, Wells Fargo and U.S. Bancorp ( USB ), have little to no presence outside this country. In the second quarter, Citigroup received 53% of its revenue, and 60% of its consumer banking profit from North America.

Citigroup's Securities and Banking unit saw a 16% net income increase over last year's highly depressed quarter, to $1.28 billion. This increased income was sustained strictly from expense reductions, most of which were personnel related. Revenue actually fell 2% from the second quarter of 2011. The investment banking industry can be forgiven for lackluster profits in the second quarter, as both North America and Europe have seen substantial reductions in mergers and acquisitions, and other capital activities. Investment banking revenues at Citigroup were down 21% from the year ago, already depressed quarter.

Citigroup has not been kind to shareholders in recent years, given its 1 for 10 reverse stock split last year, and its token dividend. After failing the Federal Reserve's Comprehensive Capital Analysis and Review, aka stress test in March, Citigroup has announced it will not seek a dividend boost or other return of capital before 2013.

There are reasons to be interested in Citigroup. Its tangible book value has climbed to over $51 per share, nearly double today's stock price. And there is little doubt in my mind that the earnings profile of the bank is growing each quarter. I used to compare Citigroup with Bank of America Corporation ( BAC ), but the two have diverged in my mind, and Citigroup is a quality candidate for big capital gains over the next two to three years.

There is also plenty of risk. Citigroup will be involved in the burgeoning LIBOR scandal . The company has far more exposure to deeply troubled Europe than any of its domestic competitors. But if you have some patience and can take a risk, Citigroup just might be for you.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

http://seekingalpha.com/article/732491-citigr...or-2-years

Citigroup Inc. (C) Stock Research Links

C Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Home Repair Shock: 85% Hit by Unplanned Costs in 2025

Updated Category News Views 142

New findings hit the floor: a staggering 85% of American homeowners coughed up cash for unplanned repairs in 2025. That’s not just pocket change; over one-third, about 38%, forked out at least $5,000 on home renovation projects. And if you're thinking that's a fluke, wait until you hear that nearly a quarter of folks (23%) dug even deeper, spending upwards of $10,000....

Continue Reading
Genialis and Debiopharm Expand Collaboration for Cancer Drug Innovation

Updated Category News Views 150

Genialis and Debiopharm's Strategic Collaboration Genialis, a pioneering RNA biomarker company, has recently announced an exciting extension of its collaboration with Debiopharm, a global biopharmaceutical leader. This partnership aims to develop predictive biomarkers specifically for therapies targeting the WEE1 protein, which is crucial in the treatment landscape of...

Continue Reading
Telecom Providers Fight Robocalls with Enhanced Solutions

Updated Category News Views 411

Progress in Robocall Mitigation by Major Telecom Providers In recent developments, top US telecom providers such as Verizon, UScellular, T-Mobile, Lumen, Comcast, Charter, and AT&T have made significant strides in maximizing their efforts against robocalls. This progress is largely attributed to the successful implementation of the STIR/SHAKEN framework, which aids in...

Continue Reading
OpenSea Unveils OS2: A Major Step Forward with $SEA Token

Updated Category News Views 238

OpenSea Launches OS2 Platform with Enhanced Trading Features The innovative marketplace, OpenSea, has rolled out its new platform known as OS2, which represents a significant transformation from its original NFT-centric model into a comprehensive trading space. This upgrade broadens its scope, allowing not just the buying and selling of NFTs but also the trading of...

Continue Reading
Experience the Future of Communications at Telecoms World Asia

Updated Category News Views 44

Join DIDWW at Telecommunications World Asia DIDWW, a renowned global provider of premium VoIP communications, is set to showcase its innovative voice and SMS solutions at the upcoming Telecoms World Asia event. This exhibition represents an incredible opportunity for telecommunications experts and businesses looking to enhance their communication strategies. What to...

Continue Reading